Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea

ClinicalTrials.gov ID: NCT01513863

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01513863. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 3:19 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo Controlled, Parallel Design, Multi-Site Clinical Study to Compare the Bioequivalence of Two Metronidazole 1% Topical Gel Formulations in Patients With Moderate to Severe Rosacea

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to demonstrate that metronidazole 1% topical gel is effective for the treatment of patients with moderate to severe rosacea.

Study identification

NCT ID
NCT01513863
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Enrollment
602 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2011 (Type not available)
Primary completion
Jun 2012 (Actual)
Completion
Sep 2012 (Actual)
Last update posted
Dec 23, 2013

2011 – 2012

United States locations

U.S. sites
22
U.S. states
14
U.S. cities
22
Facility City State ZIP Site status
Investigator Site Phoenix Arizona — —
Investigator Site Long Beach California — —
Investigator Site Newport Beach California — —
Investigator Site Denver Colorado — —
Investigator Site Jacksonville Florida — —
Investigator Site Miami Florida — —
Investigator Site Miramar Florida — —
Investigator Site Arlington Heights Illinois — —
Investigator Site Plainfield Indiana — —
Investigator Site Henderson Nevada — —
Investigator Site Hickory North Carolina — —
Investigator Site High Point North Carolina — —
Investigator Site Wilmington North Carolina — —
Investigator Site South Euclid Ohio — —
Investigator Site Hazleton Pennsylvania — —
Investigator Site Simpsonville South Carolina — —
Investigator Site Kingsport Tennessee — —
Investigator Site Knoxville Tennessee — —
Investigator Site Nashville Tennessee — —
Investigator Site San Antonio Texas — —
Investigator Site Webster Texas — —
Investigator Site West Jordan Utah — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01513863, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 23, 2013 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.